Average Co-Inventor Count = 5.07
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (53 from 2,285 patents)
2. Allegran, Inc. (1 from 1 patent)
54 patents:
1. 11208377 - 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
2. 11046644 - Sulfur derivatives as chemokine receptor modulators
3. 10993931 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
4. 10899780 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
5. 10799518 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
6. 10434112 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
7. 10287243 - Sulfur derivatives as chemokine receptor modulators
8. 10251865 - Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
9. 10208071 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
10. 10172832 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
11. 9974772 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
12. 9868700 - Carbamoyl hydrazine derivatives as formyl peptide modulators
13. 9850264 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
14. 9670150 - (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
15. 9670190 - Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators